167 related articles for article (PubMed ID: 32054948)
1. Integrative data modeling from lung and lymphatic cancer predicts functional roles for miR-34a and miR-16 in cell fate regulation.
Gupta S; Silveira DA; Barbé-Tuana FM; Mombach JCM
Sci Rep; 2020 Feb; 10(1):2511. PubMed ID: 32054948
[TBL] [Abstract][Full Text] [Related]
2. ATM/miR-34a-5p axis regulates a p21-dependent senescence-apoptosis switch in non-small cell lung cancer: a Boolean model of G1/S checkpoint regulation.
Gupta S; Silveira DA; Mombach JCM
FEBS Lett; 2020 Jan; 594(2):227-239. PubMed ID: 31545515
[TBL] [Abstract][Full Text] [Related]
3. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells.
Shi Y; Liu C; Liu X; Tang DG; Wang J
PLoS One; 2014; 9(3):e90022. PubMed ID: 24595209
[TBL] [Abstract][Full Text] [Related]
4. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
Gupta S; Hashimoto RF
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327612
[TBL] [Abstract][Full Text] [Related]
5. miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner.
Bandi N; Vassella E
Mol Cancer; 2011 May; 10():55. PubMed ID: 21575235
[TBL] [Abstract][Full Text] [Related]
6. The RNA-binding protein SART3 promotes miR-34a biogenesis and G
Sherman EJ; Mitchell DC; Garner AL
J Biol Chem; 2019 Nov; 294(46):17188-17196. PubMed ID: 31619517
[TBL] [Abstract][Full Text] [Related]
7. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
8. Characterization of miR-34a-Induced Epithelial-Mesenchymal Transition in Non-Small Lung Cancer Cells Focusing on p53.
Kawami M; Takenaka S; Akai M; Yumoto R; Takano M
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944497
[TBL] [Abstract][Full Text] [Related]
9. Mechanism research of miR-34a regulates Axl in non-small-cell lung cancer with gefitinib-acquired resistance.
Xiong R; Sun XX; Wu HR; Xu GW; Wang GX; Sun XH; Xu MQ; Xie MR
Thorac Cancer; 2020 Jan; 11(1):156-165. PubMed ID: 31777195
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a inhibits the proliferation and promotes the apoptosis of non-small cell lung cancer H1299 cell line by targeting TGFβR2.
Ma ZL; Hou PP; Li YL; Wang DT; Yuan TW; Wei JL; Zhao BT; Lou JT; Zhao XT; Jin Y; Jin YX
Tumour Biol; 2015 Apr; 36(4):2481-90. PubMed ID: 25501507
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitors inhibit metastasis by restoring a tumor suppressive microRNA-150 in advanced cutaneous T-cell lymphoma.
Abe F; Kitadate A; Ikeda S; Yamashita J; Nakanishi H; Takahashi N; Asaka C; Teshima K; Miyagaki T; Sugaya M; Tagawa H
Oncotarget; 2017 Jan; 8(5):7572-7585. PubMed ID: 27935859
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas.
Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H
Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
14. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
Jiao P; Hou J; Yao M; Wu J; Ren G
Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway.
Duan W; Xu Y; Dong Y; Cao L; Tong J; Zhou X
J Radiat Res; 2013 Jul; 54(4):611-9. PubMed ID: 23349340
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
17. A Boolean Model of the Proliferative Role of the lncRNA XIST in Non-Small Cell Lung Cancer Cells.
Gupta S; Silveira DA; Hashimoto RF; Mombach JCM
Biology (Basel); 2022 Mar; 11(4):. PubMed ID: 35453680
[TBL] [Abstract][Full Text] [Related]
18. Methylation Status of miR-34a and miR-126 in Non-Small Cell Lung Cancer (NSCLC) Tumor Tissues.
Mehrzad N; Zamani MS; Rahimi A; Shamaei M; Karimipoor M
Iran Biomed J; 2024 Jan; 28(1):53-8. PubMed ID: 38445462
[TBL] [Abstract][Full Text] [Related]
19. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
